Literature DB >> 24867834

Technique of injection of onabotulinumtoxin A for chronic migraine: the PREEMPT injection paradigm.

P Liberini1, E Pari, S Gazzina, S Caratozzolo, R Rao, A Padovani.   

Abstract

In 2013 the Italian Pharmacy Agency (AIFA) approved onabotulinumtoxin A injection to prevent headaches in adult patients with chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine) that has not responded to at least three prior pharmacological prophylaxis therapies and whose condition is appropriately managed for medication overuse. In the present paper we report the method of injection of Onabotulinumtoxin A for chronic migraine based on the PREEMPT paradigm as described by Blumenfeld et al. (Headache 50:1406-1418, 2010) adapted to our clinical setting.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24867834     DOI： 10.1007/s10072-014-1740-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  4 in total

1.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Authors:  H C Diener; D W Dodick; S K Aurora; C C Turkel; R E DeGryse; R B Lipton; S D Silberstein; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

2.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Authors:  S K Aurora; D W Dodick; C C Turkel; R E DeGryse; S D Silberstein; R B Lipton; H C Diener; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

3.  OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.

Authors:  David W Dodick; Catherine C Turkel; Ronald E DeGryse; Sheena K Aurora; Stephen D Silberstein; Richard B Lipton; Hans-Christoph Diener; Mitchell F Brin
Journal:  Headache       Date:  2010-05-07       Impact factor: 5.887

4.  Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.

Authors:  Andrew Blumenfeld; Stephen D Silberstein; David W Dodick; Sheena K Aurora; Catherine C Turkel; William J Binder
Journal:  Headache       Date:  2010-10       Impact factor: 5.887
  4 in total
  3 in total

1.  Topographic Relationship between the Supratrochlear Nerve and Corrugator Supercilii Muscle--Can This Anatomical Knowledge Improve the Response to Botulinum Toxin Injections in Chronic Migraine?

Authors:  Hyung-Jin Lee; Kwang-Seok Choi; Sung-Yoon Won; Prawit Apinuntrum; Kyung-Seok Hu; Seong-Taek Kim; Tanvaa Tansatit; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2015-07-17       Impact factor: 4.546

2.  Anatomical Regional Targeted (ART) BOTOX Injection Technique: A Novel Paradigm for Migraines and Chronic Headaches.

Authors:  Bardia Amirlak; Kyle Sanniec; Ronnie Pezeshk; Michael Chung
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-12-27

Review 3.  Anatomical Proposal for Botulinum Neurotoxin Injection for Glabellar Frown Lines.

Authors:  Kyu-Ho Yi; Ji-Hyun Lee; Hye-Won Hu; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2022-04-10       Impact factor: 4.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.